Updated:
Tuatara Capital
Tuatara Capital, co-founded by Al Foreman and Marc Riebe, is the first institutional private equity firm dedicated to the legal cannabis industry.
Tuatara Capital
Tuatara Capital was founded in 2014 by Al Foreman and Marc Riebe, former Highbridge Principal Strategies and J.P. Morgan executives who saw an institutional vacuum in the rapidly legalizing cannabis market. While most funds stayed on the sidelines due to federal prohibition and banking restrictions, Tuatara structured itself to underwrite plant-touching businesses that compliant banks and traditional PE firms could not touch. The firm operates from New York with a mandate to bring rigorous private equity discipline to a sector previously dominated by fragmented, undercapitalized operators. The firm pursues a control and growth-equity strategy across the cannabis value chain, including cultivation, processing, branded products, and retail. Tuatara's portfolio construction reflects a multi-state operator thesis, seeking platforms that can scale as new jurisdictions legalize. The firm deploys capital through discrete equity rounds rather than fund-of-funds structures. Confirmed investments include Grassroots Cannabis, a multi-state operator sold to Curaleaf in 2020 in a transaction valued at $875 million (per the firm, 2020), and High Fidelity, a Vermont-based organic cultivation and processing company. Geographic exposure spans Illinois, Massachusetts, Vermont, and other limited-license states, prioritizing markets with high regulatory barriers to entry. Tuatara closed its debut fund, Tuatara Capital Fund I, at $93 million in 2017, which Forbes described as the largest dedicated cannabis private equity vehicle at the time (per Forbes, 2017). The firm has since raised successor vehicles, though the partnership does not publicly disclose current assets under management. Team size and satellite office presence remain unpublicized. In February 2021, managing partner Al Foreman testified before the New York State Assembly regarding cannabis legalization frameworks, providing a public signal of the firm's regulatory engagement strategy (per New York State Assembly records, 2021). Tuatara's structural differentiator is not sector focus alone — it is the firm's operational posture as a federally compliant asset manager willing to hold plant-touching assets. This requires a bespoke back-office, including cash-intensive logistics and a fund administration stack that traditional PE firms reject. The partnership's long-duration holding periods and emphasis on regulatory moats distinguish it from the venture-capital approach dominant among early cannabis investors, positioning Tuatara closer to a specialized infrastructure or real-assets manager than a typical growth fund.
General information
Firm type
Generalist
Year founded
2014
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Principals
Al Foreman
Managing Partner & Co-Founder
Marc Riebe
Managing Partner & Co-Founder
Sector focus
Frequently asked questions
Who runs investment decisions at Tuatara Capital?
Al Foreman and Marc Riebe, the firm's co-founders and managing partners, lead the investment committee. Both came from institutional backgrounds — Foreman at Highbridge Principal Strategies and Riebe at J.P. Morgan — before launching Tuatara in 2014 to apply traditional private equity underwriting to the legal cannabis sector.
How does Tuatara source deal flow given federal banking restrictions?
Tuatara sources through regulatory-driven displacement. Many traditional lenders and private equity funds cannot underwrite plant-touching cannabis assets due to federal illegality, leaving a structural capital gap. The firm's compliance stack and fund structure are purpose-built to hold these assets, giving it proprietary access to operators that compliant institutions must bypass. Managing partner Al Foreman's public regulatory engagement, including testimony before the New York State Assembly in 2021, further signals a sourcing model built on jurisdictional expertise.
Is Tuatara Capital a venture capital firm or a private equity firm?
Tuatara operates as a private equity firm with a control and growth-equity mandate, not a venture capital firm. Its strategy targets operational platform companies in limited-license cannabis states, emphasizing regulatory moats and multi-state scalability. The firm's investment horizon and operational involvement distinguish it from the earlier wave of venture-style cannabis investors.
Does Tuatara participate in fund commitments alongside external GPs?
Tuatara primarily makes direct equity investments in plant-touching cannabis companies rather than committing to external funds. Its structure as an institutional private equity manager focused on a single restricted sector requires direct control and compliance oversight that fund-of-funds commitments do not provide.
What investment stages does Tuatara Capital target?
The firm targets growth-stage and control investments in operating cannabis companies, including cultivation, processing, branded products, and retail. Tuatara's 2020 exit of Grassroots Cannabis to Curaleaf for $875 million illustrates its approach: building multi-state platforms and exiting to public-company consolidators once state-level regulatory infrastructure matures.
Does federal illegality limit Tuatara's ability to raise institutional capital?
Federal illegality excludes most institutional limited partners, including public pension funds and endowments, from committing to plant-touching cannabis funds. Tuatara closed its first fund at $93 million in 2017, which was the largest dedicated cannabis PE vehicle at the time, but the LP base is limited to family offices, high-net-worth individuals, and non-federally regulated allocators who can accept the 280E tax burden and custody risks.
What is Tuatara's known posture on co-investments alongside external GPs?
Tuatara's investment model is structured around direct control and proprietary sourcing rather than club deals or co-investments. The regulatory complexity of holding plant-touching assets makes shared governance impractical with external GPs who may not maintain equivalent compliance infrastructure. The firm has not publicly disclosed co-investment arrangements with outside managers.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: